A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients
Status:
Completed
Trial end date:
2007-01-08
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate whether Neoral dose optimization together with a
therapeutic drug monitoring of Certican will prevent renal dysfunction as observed in the
pivotal cardiac trial while maintaining the efficacy.
This objective will be assessed by comparing renal function post-transplant between 2 groups
of patients.